Concourse Financial Group Securities’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Concourse Financial Group Securities's EDIT Position: Q1 2025 in Review
Concourse Financial Group Securities sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 75 shares — an estimated $100 sold.
Concourse Financial Group Securities first reported a position in EDIT in Q3 2018 and held it in 26 quarters. The position peaked at $111K in Q1 2021. 195 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.
- Concourse Financial Group Securities reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
- Concourse Financial Group Securities sold 75 Editas Medicine shares in Q1 2025, an estimated $100.
- Concourse Financial Group Securities first reported a position in Editas Medicine in Q3 2018 and held it in 26 quarters.
- Concourse Financial Group Securities's Editas Medicine position peaked at $111K in Q1 2021.
- 195 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.
Based on Concourse Financial Group Securities's 13F filing for Q1 2025.